Mather Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Mather Group’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.51K	Hold	13	–	–	﹤0.01%	1903
2026 Q2	$3.86K	Buy	+13	New	+$2.49K	﹤0.01%	1659

Other funds holding LABU

Halbert Hargrove Global Advisors Long Beach, California $2.29B AUM 13.62% 1-Year Est. Return

Mather Group's LABU Position: Q3 2026 in Review

Mather Group held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q3 2026 at 13 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

Mather Group first reported a position in LABU in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.86K in Q2 2026. 2 funds tracked by Wall St. Rank hold LABU as of Q3 2026.

Mather Group held 13 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $3.51K as of Q3 2026.
Mather Group left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q3 2026.
Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1903 holding.
Mather Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2026 and has held it in 2 quarters since.
Mather Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3.86K in Q2 2026.
2 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.